Literature DB >> 4369426

Utilization of ascites plasma very low density lipoprotein triglycerides by Ehrlich cells.

D E Brenneman, A A Spector.   

Abstract

Much of the lipid present in the ascites plasma in which Ehrlich cells grow is contained in very low density lipoproteins (VLDL). Chemical measurements indicated that triglycerides were taken up by the cells during in vitro incubation with ascites VLDL. When tracer amounts of radioactive triolein were incorporated into the ascites VLDL, the percentage uptakes of glyceryl tri[1-(14)C]oleate and triglycerides measured chemically were similar. The cells also took up [2-(3)H]glyceryl trioleate that was added to VLDL, but the percentage of available (3)H recovered in the cell lipids was 30-40% less than that of (1 4)C from glyceryl tri[1-(1 4)C]oleate. This difference was accounted for by water-soluble (3)H that accumulated in the incubation medium, suggesting that extensive hydrolysis accompanied the uptake of VLDL triglycerides. Radioactive fatty acids derived from the VLDL triglycerides were incorporated into cell phospholipids, glycerides, and free fatty acids, and they also were oxidized to CO(2). Triglyceride utilization increased as the VLDL concentration was raised. These results suggest that one function of the ascites plasma VLDL may be to supply fatty acid to the Ehrlich cells and that the availability of fatty acid to this tumor is determined in part by the ascites plasma VLDL concentration. Although Ehrlich cells incorporate almost no free glycerol into triglycerides, considerable amounts of [2-(3)H]glyceryl trioleate radioactivity were recovered in cell triglycerides. This indicates that at least some VLDL triglycerides were taken up intact. The net uptake of VLDL protein and cholesterol was very small relative to the triglyceride uptake, suggesting that intact triglycerides are transferred from the ascites VLDL to the Ehrlich cells and that hydrolysis occurs after the triglyceride is associated with the cells.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4369426

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.

Authors:  K Sakayama; H Masuno; H Okumura; T Shibata; H Okuda
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

2.  The contribution of serum triacylglycerol to hepatic triacylglycerol turnover in the starved rat.

Authors:  E W Lipkin; C Cooper; R A Shipley
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

3.  Lipid accumulation cells derived from porcine aorta and grown under anaerobic conditions.

Authors:  R G Briggs; J L Glenn
Journal:  Lipids       Date:  1976-11       Impact factor: 1.880

4.  Metabolism of fatty acid, glycerol and a monoglyceride analogue by rat cardiac myocytes and perfused hearts.

Authors:  A Tamboli; M Vander Maten; P O'Looney; G V Vahouny
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

5.  Regulation of fatty acid biosynthesis in Ehrlich cells by ascites tumor plasma lipoproteins.

Authors:  R McGee; D E Brenneman; A A Spector
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

6.  Lipid mobilising factors specifically associated with cancer cachexia.

Authors:  S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

7.  Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo.

Authors:  L A Sauer; R T Dauchy
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

8.  Existence of lipoprotein lipase in human sarcomas and carcinomas.

Authors:  K Sakayama; H Masuno; T Miyazaki; H Okumura; T Shibata; H Okuda
Journal:  Jpn J Cancer Res       Date:  1994-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.